Semquest 6 mg/0,4 mg tablete s prilagođenim oslobađanjem
| Name | Semquest 6 mg/0,4 mg tablete s prilagođenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-189973461 |
| Active Substance | solifenacinsukcinat tamsulozinklorid |
| Composition | jedna tableta sadrži sloj sa 6 mg solifenacinsukcinata, što odgovara 4,5 mg solifenacina i sloj s 0,4 mg tamsulozinklorida, što odgovara 0,37 mg tamsulozina |
| Pharmaceutical Form | tableta s prilagođenim oslobađanjem |
| Manufacturer | Adamed Pharma S.A., Pabianice, Poljska |
| Marketing Authorisation Holder | Bausch Health Ireland Limited, 3013 Lake Drive, Citywest Business Campus, Dublin 24, Irska |
| Marketing Authorisation Date | 27.07.2022 |
| MA Period of Validity | 27.07.2027 |
| Classification Number | UP/I-530-09/21-01/117 |
| Registration Number | 381-12-01/154-22-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | G04CA53 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
